Abeona Therapeutics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ABEO, updated each market day.
ABEO AI Sentiment
AI predicts Abeona Therapeutics Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Abeona Therapeutics Inc. Common Stock
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Sector
Exchange
Market Cap
$292,090,997
Cap Tier
Employees
226
Headquarters
CLEVELAND, OH
Listed Since
Sept. 19, 1980
ABEO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ABEO Volatility
Abeona Therapeutics Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
